Artesunate Patent Expiration

Artesunate was first introduced by Amivas Inc in its drug Artesunate on May 26, 2020.

Artesunate Patents

Given below is the list of patents protecting Artesunate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Artesunate	US12121506	Artesunate powders, pharmaceutical compositions and methods of manufacture	Feb 16, 2044	Amivas

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List